Delivery Order SPE2DB20D1109-SPE2DB25FP01P

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of NUCYNTA ER 100 mg tablets, with a total ceiling value of $1,388.98 and a period of performance through October 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.33, is for the delivery of NUCYNTA ER 50 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NUCYNTA ER 200 MG TABLET 60S, a pharmaceutical product, with a potential value of $2,275.44 and a completion date of March 5, 2024. The contract is a firm fixed price type and does not have a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 MG TABLET 60S. The contract is a firm fixed-price, delivery order contract with a ceiling value of $5,671.18 and an ultimate completion date of October 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 100 mg tablets. The contract has a ceiling value of $2,544.90 and a completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUCYNTA ER 200 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $1,941.77, and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 250 MG TABLET 60S. The contract has a ceiling value of $8,370.02 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the provision of NUCYNTA ER 50 mg tablets. The $9,732.21 firm-fixed-price contract has a completion date of May 29, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical, valued up to $999,999,999.00 through 2025, and the Department of Justice Federal Bureau of Investigation, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 200 MG TABLET 60S. The $10,839.70 contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,472.04 firm fixed-price contract is for the delivery of NUCYNTA ER 100 MG TABLET 60S, a prescription pain medication. The contract has a period of performance through March 17, 2025 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP01P
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 mg tablets. The contract has a firm fixed price of $1,592.44 and a performance period through May 7, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business size or socioeconomic category.

Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order appears to be part of that broader IDC, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military and other government healthcare programs.

Generated 8/10/25, 1:11 AM